Celestica (NYSE:CLS) Shares Down 5.6% - Time to Sell?

Celestica, Inc. (NYSE:CLS - Get Free Report) TSE: CLS's share price fell 5.6% on Friday. The stock traded as low as $228.76 and last traded at $239.8880. 3,474,643 shares changed hands during trading, an increase of 37% from the average daily volume of 2,541,308 shares. The stock had previously closed at $254.03.

Latest Celestica News

Investors following CLS have been watching these news items:

• Positive Sentiment: Celestica raised its 2027 outlook after sales increased 83%, signaling stronger growth expectations and supporting the company’s long-term investment case. Celestica Raised Its 2027 Outlook After Sales Jumped 83%: Is It Too Late to Buy?
• Positive Sentiment: A growth-investor feature highlights Celestica’s above-average financial growth as a reason it may outperform, reinforcing optimism around its business trajectory. 3 Reasons Growth Investors Will Love Celestica
• Neutral Sentiment: Investors have been searching for CLS, but the coverage describes attention rather than a new business catalyst. Investors Heavily Search Celestica, Inc. (CLS): Here is What You Need to Know

Analyst Ratings Changes

A number of equities research analysts have weighed in on CLS shares. Citigroup raised their price target on Celestica from $415.00 to $436.00 and gave the company a "buy" rating in a research report on Wednesday, October 28th. Scotiabank initiated coverage on Celestica in a research note on Tuesday, August 11th. They set a "sector outperform" rating and a $500.00 price target for the company. BMO Capital Markets reiterated an "outperform" rating and issued a $400.00 price objective on shares of Celestica in a report on Friday, October 23rd. Zacks Research upgraded Celestica from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, November 3rd. Finally, UBS Group increased their price objective on Celestica from $430.00 to $453.00 and gave the company a "buy" rating in a research report on Wednesday, October 28th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus price target of $445.14.

Celestica Stock Performance

The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.03 and a current ratio of 1.61. The business has a 50 day moving average price of $312.83 and a two-hundred day moving average price of $327.85. The company has a market cap of $30.25 billion, a P/E ratio of 22.70, a price-to-earnings-growth ratio of 1.70 and a beta of 2.10.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last posted its quarterly earnings results on Monday, October 26th. The technology company reported $3.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.02 by $0.28. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.39 billion. Celestica had a return on equity of 33.80% and a net margin of 6.83%. On average, sell-side analysts anticipate that Celestica, Inc. will post 10.97 earnings per share for the current year.

Insider Activity at Celestica

In related news, CEO Robert Mionis sold 23,396 shares of the company's stock in a transaction on Wednesday, September 23rd. The shares were sold at an average price of $364.22, for a total transaction of $8,521,291.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, President Todd C. Cooper sold 20,118 shares of the company's stock in a transaction on Wednesday, September 23rd. The shares were sold at an average price of $360.00, for a total transaction of $7,242,480.00. Following the sale, the president owned 73,252 shares of the company's stock, valued at $26,370,720. This represents a 21.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.10% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Celestica

A number of hedge funds have recently modified their holdings of CLS. Insigneo Advisory Services LLC raised its stake in shares of Celestica by 9.9% during the third quarter. Insigneo Advisory Services LLC now owns 1,421 shares of the technology company's stock valued at $514,000 after acquiring an additional 128 shares during the last quarter. Evolutionary Tree Capital Management LLC boosted its holdings in shares of Celestica by 28.6% during the third quarter. Evolutionary Tree Capital Management LLC now owns 7,354 shares of the technology company's stock worth $2,658,000 after purchasing an additional 1,637 shares during the period. Fiduciary Financial Advisors boosted its holdings in shares of Celestica by 51.0% during the third quarter. Fiduciary Financial Advisors now owns 933 shares of the technology company's stock worth $334,000 after purchasing an additional 315 shares during the period. Essex Financial Services Inc. grew its stake in shares of Celestica by 8.4% in the third quarter. Essex Financial Services Inc. now owns 1,344 shares of the technology company's stock worth $486,000 after purchasing an additional 104 shares during the last quarter. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its stake in shares of Celestica by 26.8% in the third quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 234,687 shares of the technology company's stock worth $84,924,000 after purchasing an additional 49,599 shares during the last quarter. Hedge funds and other institutional investors own 67.38% of the company's stock.

Celestica Company Profile

Celestica Inc. is a global provider of design, manufacturing, and supply chain services for companies across technology and industrial markets. Its work spans product development, engineering, manufacturing, testing, and ongoing product support. The company's offerings include hardware and infrastructure used in cloud computing and data centers, communications networks, aerospace and defense, industrial equipment, and health technology. It also provides supply chain management and other services to support products throughout their lifecycle.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.